Susan Fotheringham Department of Medical Oncology Dana-Farber Cancer Institute Biography Publications Institution JoVE Articles Susan Fotheringham has not added a biography. If you are Susan Fotheringham and would like to personalize this page please email our Author Liaison for assistance. Publications HR23B is a Biomarker for Tumor Sensitivity to HDAC Inhibitor-based Therapy Proceedings of the National Academy of Sciences of the United States of America. Apr, 2010 | Pubmed ID: 20308564 Genome-wide Loss-of-function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-induced Apoptosis Cancer Cell. Jan, 2009 | Pubmed ID: 19111881 الثقافة السابقين فيفو من خلايا الإنسان الأولية قناة فالوب طلائي Susan Fotheringham1,2, Keren Levanon1,2,3, Ronny Drapkin1,2,4 1Department of Medical Oncology, Dana-Farber Cancer Institute, 2Harvard Medical School, Boston, MA, 3Sheba Cancer Research Center, Chaim Sheba Medical Center, 4Department of Pathology, Brigham and Women's Hospital JoVE 2728 Biology
الثقافة السابقين فيفو من خلايا الإنسان الأولية قناة فالوب طلائي Susan Fotheringham1,2, Keren Levanon1,2,3, Ronny Drapkin1,2,4 1Department of Medical Oncology, Dana-Farber Cancer Institute, 2Harvard Medical School, Boston, MA, 3Sheba Cancer Research Center, Chaim Sheba Medical Center, 4Department of Pathology, Brigham and Women's Hospital JoVE 2728 Biology
